"Designing Growth Strategies is in our DNA"
A platelet incubator is a medical device designed to store platelet concentrates at a controlled temperature, typically between 20°C and 24°C, to maintain their quality and viability for transfusion. These incubators are used in hospitals, blood banks, and research settings to ensure the optimal storage environment for platelets after their collection. They often come with integrated platelet agitators that move the platelet bags in a controlled manner to prevent sedimentation and maintain the platelets' quality.
The growing incidence of chronic diseases such as cardiovascular disorders and thrombocytopenia (a condition characterized by a low blood platelet count) is expected to fuel market growth in the coming years. These conditions are most often treated with a platelet transfusion, which is driving the utilization of the platelet incubators for the storage of the donor platelets prior to the transfusion.
Furthermore, the platelet transfusion process is also carried out in patients with leukemia, aplastic anemia, myelodysplasia, inherited or acquired/medication-induced platelet dysfunction, solid tumors, central nervous system trauma, and patients undergoing cardiopulmonary bypass. These indications together are expected to boost the usage of platelet incubators, driving market growth in the coming years.
Moreover, the advancements in these platelet storage systems, such as the introduction of intelligent controllers that automatically maintain continuity in operations and the emergence of digital temperature recorders for optimal accuracy, are propelling the demand for platelet incubators. This is expected to boost the market growth during the forecast period.
The COVID-19 pandemic had a positive impact on the platelet incubator market. The pandemic led to a surge in the number of platelet transfusions, particularly for COVID-19 patients requiring critical care. This fueled the demand for platelet incubators, driving the market growth in 2020.
|
By Product Type |
By Type |
By End-user |
By Geography |
|
|
|
|
The report covers the following key insights:
Based on the product type, the market is categorized into bench-top and floor-standing. The floor-standing segment is projected to account for a significant share of the global platelet incubator market during the forecast period. The floor-standing models are used more frequently due to their higher capacity and flexibility in terms of accommodating the multiple platelet agitators. This allows them to handle larger volumes of platelet storage, making them more suitable for laboratories and blood banks that require efficient and reliable storage solutions. These benefits associated with the floor-standing incubators are expected to boost segmental growth in the coming years.
On the other hand, the bench-top segment is anticipated to grow at a significant CAGR during the forecast period. The bench-top incubators typically have lower capacities compared to the floor-standing incubators, which makes them more suitable for smaller-scale operations or those with limited space. This is expected to boost the segment growth in the coming years. Furthermore, the rising use of these incubators in the blood banks due to its moderate storage capacity for platelet concentrates, ranging from a few to several units is also projected to boost its demand, driving the segment growth in the forthcoming years.
To gain extensive insights into the market, Download for Customization
The global market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America is expected to hold a significant share of the platelet incubator market during the forecast period. The market growth of this region is primarily attributed to the significant diagnostic rate of blood-related disorders, including aplastic anemia, in countries such as the U.S. This is driving the need for platelet transfusion procedures in the region, propelling the demand for platelet incubators. In such a case, the regional market is expected to grow significantly during the forecast period.
Asia Pacific is expected to grow at a significant CAGR during the forecast period. The growth is attributed to the growing awareness regarding blood-related disorders in the region. The rising diagnoses of these conditions are propelling the demand for these incubators in the region. In addition, the increasing geriatric population in the region is expected to increase the risk of such disorders, fueling the demand for platelet transfusion. These factors are expected to boost the utilization of platelet incubators, driving market growth in the forthcoming years.
The market consists of significant players, such as Helmer Scientific Inc., NÜVE SANAYΔ° MALZEMELERΔ° Δ°MALAT VE TΔ°CARET A.Ε. Biolab Scientific, Terumo Corporation, Meditech, BIOBASE BIODUSTY(SHANDONG), Co., Ltd., and Boekel Scientific.
Get In Touch With Us
US +1 833 909 2966 ( Toll Free )